News
UNITY Biotechnology Completes Enrollment in Phase 1b Study of UBX0101
– Topline 12- and 24-week results expected in 2H 2020 –SAN FRANCISCO, March 31, 2020 (GLOBE NEWSWIRE) — UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing…
Share
Osteoporosis Drugs Market to Reach $10.47 Billion by 2026: AMR
Increase in prevalence of osteoporosis, increase in the aging population, and adoption of sedentary lifestyle across the world drive the growth of the global osteoporosis drugs market…
Share
INCYSUS THERAPEUTICS TO PRESENT AT THE NYC SPRING ONCOLOGY INVESTOR CONFERENCE
NEW YORK, March 31, 2020 (GLOBE NEWSWIRE) — Incysus Therapeutics, Inc. (“Incysus”), a clinical-stage biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell…
Share
CytoDyn Completes Non-dilutive $15 Million Convertible Note Financing with Conversion Rate at $4.50 Per Share without Warrants
VANCOUVER, Washington, March 31, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a…
Share
Myriad Seeks Japanese Regulatory Approval for its BRACAnalysis® Diagnostic System in People with Advanced Pancreatic and Prostate Cancer
SALT LAKE CITY, March 30, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, announced it has submitted a supplementary…
Share
Three Additional Patients with Severe COVID-19 Treated with Leronlimab in New York Medical Center Bringing the Total to 10 Patients
VANCOUVER, Washington, March 30, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a…
Share
ENTERA BIO LTD ANNOUNCES FINANCIAL AND OPERATING RESULTS FOR THE FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2019
‒ Three Month Biomarker Data from Phase 2 Clinical Trial of EB613 Expected in the Second Quarter of 2020 with Additional Data Readouts Expected in 2020 and Early 2021 ‒‒ Financing Completed…
Share
Global Diabetes Drugs Market 2020 to Showing Impressive Growth by 2025 | Industry Trends, Share, Size, Top Key Players Analysis and Forecast – 360 Market Updates
Pune, March 02, 2020 (GLOBE NEWSWIRE) — Global “Diabetes Drugs” market report 2020 – 2025 offers a far-reaching analysis of key drivers, leading market players, key segments, and regions…
Share